Inclusion bodies: Formation and utilisationFAHNERT, Beatrix; LILIE, Hauke; NEUBAUER, Peter et al.Advances in biochemical engineering, biotechnology. 2004, Vol 89, pp 93-142, issn 0724-6145, 50 p.Article

An approach for increasing the mass recovery of proteins derived from inclusion bodies in biotechnologyDAN WU; CHAOZHAN WANG; XINDU GENG et al.Biotechnology progress. 2007, Vol 23, Num 2, pp 407-412, issn 8756-7938, 6 p.Article

Direct refolding of inclusion bodies using reversed micellesSAKONO, Masafumi; KAWASHIMA, Yu-Mi; ICHINOSE, Hirofumi et al.Biotechnology progress. 2004, Vol 20, Num 6, pp 1783-1787, issn 8756-7938, 5 p.Article

Efficient inclusion body processing using chemical extraction and high gradient magnetic fishingHEEBØLL-NIELSEN, Anders; CHOE, Woo-Seok; MIDDELBERG, Anton P. J et al.Biotechnology progress. 2003, Vol 19, Num 3, pp 887-898, issn 8756-7938, 12 p.Article

Myosites à inclusions = Inclusion body myositisTOME, F. M. S; FARDEAU, M.La Revue du praticien (Paris). 1988, Num 22, pp 1529-1532, issn 0035-2640Article

The economics of inclusion body processingLEE, G. H; COONEY, D; MIDDELBERG, A. P. J et al.Bioprocess and biosystems engineering (Print). 2006, Vol 29, Num 2, pp 73-90, issn 1615-7591, 18 p.Article

Characterization of inclusion bodies with cytoprotective properties formed by seipinopathy-linked mutant seipinITO, Daisuke; YAGI, Takuya; IKAWA, Masahito et al.Human molecular genetics (Print). 2012, Vol 21, Num 3, pp 635-646, issn 0964-6906, 12 p.Article

Localization of functional polypeptides in bacterial inclusion bodiesGARCIA-FRUITOS, Elena; ARTS, Anna; VILLAVERDE, Antonio et al.Applied and environmental microbiology (Print). 2007, Vol 73, Num 1, pp 289-294, issn 0099-2240, 6 p.Article

Familial inflammatory inclusion body myositisRANQUE-FRANCOIS, B; MAISONOBE, T; DION, E et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 4, pp 634-637, issn 0003-4967, 4 p.Article

Recovery of active N-acetyl-D-glucosamine 2-epimerase from inclusion bodies by solubilization with non-denaturing buffersLU, Shih-Chin; LIN, Sung-Chyr.Enzyme and microbial technology. 2012, Vol 50, Num 1, pp 65-70, issn 0141-0229, 6 p.Article

In Vivo Enzyme Immobilization by Inclusion Body DisplaySTEINMANN, Björn; CHRISTMANN, Andreas; HEISELER, Tim et al.Applied and environmental microbiology (Print). 2010, Vol 76, Num 16, pp 5563-5569, issn 0099-2240, 7 p.Article

Amiodarone and multilamellar inclusionsADAMS, P. C; HOLT, D. W.British journal of clinical pharmacology. 1987, Vol 24, Num 2, issn 0306-5251, 239Article

Aggresomes and pericentriolar sites of virus assembly : Cellular defense or viral design?WILEMAN, Thomas.Annual review of microbiology. 2007, Vol 61, pp 149-167, issn 0066-4227, 19 p.Article

Formation of active inclusion bodies in the periplasm of Escherichia coliARIE, Jean-Philippe; MIOT, Marika; SASSOON, Nathalie et al.Molecular microbiology (Print). 2006, Vol 62, Num 2, pp 427-437, issn 0950-382X, 11 p.Article

La myosite à inclusions = Inclusion body myositisSERRATRICE, G.La Presse médicale (1983). 1996, Vol 25, Num 21, pp 985-988, issn 0755-4982Article

Factors influencing aggregation of macromolecules in solutionPERSSON, K. M; GEKAS, V.Process biochemistry (1991). 1994, Vol 29, Num 2, pp 89-98, issn 1359-5113Article

Techno-Economic Evaluation of an Inclusion Body Solubilization and Recombinant Protein Refolding ProcessFREYDELL, Esteban J; VAN DER WIELEN, Luuk A. M; EPPINK, Michel H. M et al.Biotechnology progress. 2011, Vol 27, Num 5, pp 1315-1328, issn 8756-7938, 14 p.Article

Analysis of NCAM helps identify unusual phenotypes of hereditary inclusion-body myopathyBROCCOLINI, A; GIDARO, T; TASCA, G et al.Neurology. 2010, Vol 75, Num 3, pp 265-272, issn 0028-3878, 8 p.Article

Strategy for selection of methods for separation of bioparticles from particle mixturesVAN HEE, P; HOEBEN, M. A; VAN DER LANS, R. G. J. M et al.Biotechnology and bioengineering. 2006, Vol 94, Num 4, pp 689-709, issn 0006-3592, 21 p.Article

The impact of DnaKJ overexpression on recombinant protein solubility results from antagonistic effects on the control of protein qualityPETERSSON, Lisa; CARRIO, M. Mar; VERA, Andrea et al.Biotechnology letters. 2004, Vol 26, Num 7, pp 595-601, issn 0141-5492, 7 p.Article

Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradationWEIHL, Conrad C; DALAL, Seema; PESTRONK, Alan et al.Human molecular genetics (Print). 2006, Vol 15, Num 2, pp 189-199, issn 0964-6906, 11 p.Article

NCAM is hyposialylated in hereditary inclusion body myopathy due to GNE mutationsRICCI, E; BROCCOLINI, A; GIDARO, T et al.Neurology. 2006, Vol 66, Num 5, pp 755-758, issn 0028-3878, 4 p.Article

Neurodegeneration caused by proteins with an aberrant carboxyl-terminusVIDAL, Ruben; DELISLE, Marie Bernadette; GHETTI, Bernardino et al.Journal of neuropathology and experimental neurology. 2004, Vol 63, Num 8, pp 787-800, issn 0022-3069, 14 p.Article

Optimized procedures for purification and solubilization of basic fibroblast growth factor inclusion bodiesESTAPE, D; RINAS, U.Biotechnology techniques. 1996, Vol 10, Num 7, pp 481-484, issn 0951-208XArticle

Mutations in human interferon gamma affecting inclusion body formation identified by a general immunochemical screenWETZEL, R; JEANNE PERRY, L; VEILLEUX, C et al.Bio/technology (New York, N.Y. 1983). 1991, Vol 9, Num 8, pp 731-737, issn 0733-222XArticle